R
RiverMend Health
Evidence-based addiction and eating disorder treatment with a multidisciplinary approach for lifelong recovery
About RiverMend Health
RiverMend Health is a leading provider of scientifically driven addiction medicine and treatment for eating disorders and obesity. The company operates in the healthcare sector, focusing on individuals struggling with addiction, eating disorders, and obesity. RiverMend Health serves a diverse clientele, including patients, clinicians, families, and alumni, offering a range of services designed to promote lifelong recovery. The business model revolves around providing comprehensive, evidence-based treatment programs through a nationwide network of leading addiction recovery experts and treatment centers. Revenue is generated through patient services, insurance reimbursements, and specialized treatment programs. The company emphasizes a multidisciplinary approach that combines medical science with restorative therapies to address the complex medical, emotional, and psychological issues associated with addiction and eating disorders.
Source: Dealroom company dataNews
Open roles
RiverMend Health in the Marietta ecosystem
The RiverMend Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about RiverMend Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RiverMend Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



